GrantExec

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)

This funding opportunity supports researchers investigating how certain diabetes medications may influence cancer risk, particularly in relation to obesity-related cancers, through innovative mechanistic studies.

$275,000
Closed
Nationwide
Key Dates

Application Opens

August 24, 2023

Application Closes

November 17, 2024

Contact Information

Grantor

NIH Grants Information

Subscribe to view contact details

Newsletter Required
Categories
Education
Health